Kiromic BioPharma

KRPB

Holzer & Holzer, LLC informs investors that a class action lawsuit was filed against Kiromic BioPharma, Inc. (“Kiromic” or the “Company”) (NASDAQ: KRPB).  The lawsuit alleges Kiromic failed to disclose that the FDA imposed a clinical hold for two of its new drug candidates prior to the filing of the Registration Statement and Prospectus, contrary to assurances the Company made to investors. If you bought shares of Kiromic between June 25, 2021 and August 13, 2021, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com to learn more. The deadline to ask the court to be appointed lead plaintiff in the case is October 4, 2022.

Registration Deadline

Lead Plaintiff Deadline Has Passed

October 4, 2022

Submit Your Information

Name
Address
Shares Purchased
Date Puchased
Number of Shares Acquired
Acquisition Price Per Share
 
Shares Sold
Date Sold
Number of Shares Sold
Selling Price Per Share
 
By clicking on the button below, I am requesting Holzer & Holzer, LLC send me documents necessary to retain the firm.